Chronic Kidney Disease - Peridialysis Period: Predialysis, Dialysis Preparation, and Initial Dialysis Prescription

1 Petrov A, Benkova-Petrova M, Petrov, Koleva R, Zhelyazkov K, Stavreva A, et al. [Frequency of chronic kidney disease among the population of Dalgopol municipality, Varna district - results from screening campaign of the clinic of nephrology]. Current Nephrology. 2021;1(15):32-38. Bulgarian. Search in Google Scholar

2 Chronic Kidney Disease Prognosis Consortium, Matsushita K, Van der Velde M, Astor B, WoodwardM, Levey A, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81. Search in Google Scholar

3 Yang C, Gao B, Zhao X, Su Z, Sun X, Wang H, et al. Executive summary for China kidney disease network (CK-NET) 2016 Annual Data Report. Kidney Int. 2020;98(6):1419-23. Search in Google Scholar

4 Robinson B, Zhang J, Morgenstern H, Bradbury B, Leslie J, NgKeith P, et al. Worldwide, mortality risk is soon high after the initiation of hemodialysis. Kidney Int. 2014;85(1):158-65. Search in Google Scholar

5 Chinese Experts Group of the Guideline for the Management of “CKD-PeriDialysis”, Chinese Non-government Medical Institutions Association. Chinese Clinical Practice Guideline for the Management of “CKD-PeriDialysis”- the Periods Prior to and in the Early-Stage of Initial Dialysis. Kidney Int Rep. 2022;7(12):531-58. Search in Google Scholar

6 Gu X, Fang X. Diagnosis stages and epidemiologic studies of chronic kidney disease in elderly adults. Chin J Geriatr. 2016;35(5):556-59. Search in Google Scholar

7 Yang C, Yang Z, Wang J, Wang H, Su Z, Chen R, et al. Estimation of prevalence of kidney disease treated with dialysis in China: a study of insurance claims data. Am J Kidney Dis. 2021;77(6):889-97. Search in Google Scholar

8 Zhang L, Zhao M, Zuo L,Wang Y, Yu F, Zhang H, et al. China Kidney Disease Network (CKNET) 2016 annual data report. Kidney Int Suppl (2011). 2020;10(2):97-185. Search in Google Scholar

9 Nee R, Fisher E, Yuan, Agodoa LY, Abbott KC. Pre-end-stage renal disease care and early survival among incident dialysis patients in the US military health system. Am J Nephrol. 2017;45(6):464-72. Search in Google Scholar

10 Eckardt K, Gillespie I, Kronenberg F, Sharon R, Stenvinkel P, Anker S, et al. High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int. 2015;88(5):1117-125. Search in Google Scholar

11 Kalantar-Zadeh K, Kovesdy C, Streja E, Rhee K, Soohoo M, Chen J, et al. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant. 2017;32(2):91-8. Search in Google Scholar

12 Ashikova KA. Тrends For Erythropoietin Stimulating Agents. Journal Of Medical Science and Clinical Research-JMSCR. 2020;8(7):378-87. Search in Google Scholar

13 Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150. Search in Google Scholar

14 Eckardt K, Bansal N, Coresh J, Evans M, Grams M, Herzog C, et al. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4 þ): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018;93(6):1281-92. Search in Google Scholar

15 Waijer S, de Vries S, Busch R, Xie D, Gansevoort R, Hou F, et al. Large between-patient variability in eGFR decline before clinical trial enrollment and impact on atrasentan’s efficacy-a post-hoc analysis from the SONAR trial. J Am Soc Nephrol. 2021;32(11):2731-34. Search in Google Scholar

16 Cheung A, Chang T, Cushman W, Furth S, Hou F, Joachim H, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3):559-69. Search in Google Scholar

17 Williams B, Mancia G, Spiering W, Williams B, Giuseppe M., Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. Search in Google Scholar

18 Cheung A, Chang T, Cushman W, Alfred K, Cheung T, Chang W, et al. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95(5):1027-36. Search in Google Scholar

19 Sarafidis P, Persu A, Agarwal R, Burnier M, Leeuw P, Ferro C, et al. Hypertension in dialysis patients: a consensus document by the European Renal and cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA–EDTA) and the hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant. 2017;35(4):620-40. Search in Google Scholar

20 Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese Guidelines for diagnosis and treatment of heart failure 2018. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46(10):760-89. Search in Google Scholar

21 Donciu M, Voroneanu L, Covic A. Volume overload in CKD: pathophysiology, assessment techniques, consequences and treatment. CardioRenal Clinical Challenges. 2015;12:119-44. Search in Google Scholar

22 Yancy C, Jessup M, Bozkurt B, Butler J, Donald E, Casey DE Jr, et al. 2017 ACC/AHA/ HFSA Focused Update of the 2013 ACCF/ AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):137-61. Search in Google Scholar

23 Bansal N, Zelnick L, Ballantyne C, Chaves P, Christenson R, Coresh J, et al. Upper reference limits for high-sensitivity cardiac troponin T and N-terminal fragment of the prohormone brain natriuretic peptide in patients with CKD. Am J Kidney Dis. 2022;79(3):383-92. Search in Google Scholar

24 Jafri L, Kashif W, Tai J, Siddiqui I, Azam I, Shahzad H, et al. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function. BMC Nephrol. 2013;31(14):117. Search in Google Scholar

25 Valdivielso J, Balafa O, Ekart R, Ferro C, Mallamaci F, Mark P, et al. Hyperkalemia in chronic kidney disease in the New Era of kidney protection therapies. Drugs. 2021;81(13):1467-89. Search in Google Scholar

26 Kovesdy C, Matsushita K, Sang Y, Nigel J, Carrero J, Chodick G, et al. Serum potassium and adverse outcomes across the range of kidney function: a CKD prognosis consortium meta-analysis. Eur Heart J. 2018;399(17):1535-42. Search in Google Scholar

27 Dhondup T, Qian Q. Acid-base and electrolyte disorders in patients with and without chronic kidney disease: an update. Kidney Dis (Basel). 2017;3(4):136-48. Search in Google Scholar

28 Mclean A, Nath M, Sawhney S. Population Epidemiology of Hyperkalemia: Cardiac and Kidney Long-term Health Outcomes. Am J Kidney Dis. 2022;79(4):527-38. Search in Google Scholar

29 KDIGO. Clinical practice guideline update for the evaluation, prevention, and diagnosis of chronic kidney disease– mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. Search in Google Scholar

30 Sardiwal S, Magnusson P, Goldsmith D, Lamb E. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis. 2013;62(4):810-22. Search in Google Scholar

31 Drechsler C, Verduijn V, Pilz S, Krediet R, Dekker F, Wanner C, et al. Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1752-59. Search in Google Scholar

32 Ott S, Malluche H, Jorgetti V, Elder G. Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. Kidney Int. 2021;100(3):502-5. Search in Google Scholar

33 Yankova M, Todorova G, Todorov V. Age-related characteristics of mineral and bone metabolism in patients with chronic kidney disease. J Biomed Clin Res 2022; 15 (2), 165-70. Search in Google Scholar

34 Ikizler T, Burrowes J, Byham-Gray L, Campbell K, Carrero J, Winnie C, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3):1107. Search in Google Scholar

35 Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Gossum A, Klek S, et al. Diagnostic criteria for malnutrition - an ESPEN Consensus Statement. Clin Nutr. 2015;3(3)4:335-40. Search in Google Scholar

36 KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279-335. Search in Google Scholar

37 Mikhail A, Brown C, Williams J, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on anaemia of Chronic Kidney Disease. BMC Nephrol. 2017;18(1):345. Search in Google Scholar

38 Dinh N, Cheanh B, Tran L. The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening irondeficiency anemia among patients with end-stage renal disease: a retrospective analysis. BMC Nephrol. 2020;21(1):142. Search in Google Scholar

39 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4):1-115. Search in Google Scholar

40 Bighnam M. In this issue of diabetes care. Diabetes Care. 2019;42(1):1-2. Search in Google Scholar

41 Narva A, Norton J, Boulware L. Educating patients about CKD: the path to self-management and patientcentered care. Clin J Am Soc Nephrol. 2016;11(4):694-703. Search in Google Scholar

42 Chu C, Mc Cullch, BT, Pavkov M, Burrows N, Gillespie B, et al. CKD awareness among US adults by future risk of kidney failure. Am J Kidney Dis. 2020;76(2):174-83. Search in Google Scholar

43 National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884-930. Search in Google Scholar

44 Chan C, Blankjestin P, Dember L, Gallieni M, Harris D, Lok CE, et al. Dialysis initiation modality, choice, access, and prescription: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37-47. Search in Google Scholar

45 Blood Purification Access Group. Blood Purification Center Management Branch, Chinese Hospital Association. Chinese Expert Consensus on Vascular Access for Hemodialysis (1st version). Chin J Blood Purif. 2014;13:549-58. Search in Google Scholar

46 Kulawik D, Sands J, Mayo K, Fenderson M, Hutchinson J, Woodward C, et al. Focused vascular access education to reduce the use of chronic tunneled hemodialysis catheters: results of a network quality improvement initiative. Semin Dial. 2009;22(6):692-97. Search in Google Scholar

47 Murea M, Woo K. New frontiers in vascular access practice: from standardized to patient-tailored care and shared decision making. Kidney360. 2021;2(8):1380-89. Search in Google Scholar

48 Collins J, Cooper B, Branley P, Bulfone L, Craig J, Fraenkel M, et al. Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial. Contrib Nephrol. 2011;171:1-9. Search in Google Scholar

49 Flythe J, Dorough A, Narendra J, Wingard R, Dalrymple L, DeWalt D. Development and content validity of a hemodialysis symptom patient-reported outcome measure. Qual Life Res. 2019;28(1):253-65. Search in Google Scholar

50 Hcu C, Parikh R, Pravoverov L, Zheng S, Glidden D, Tan T, et al. Implication of trends in timing of dialysis initiation for incidence of end stage kidney disease. JAMA Intern Med. 2020;180(12):1647-54. Search in Google Scholar

51 Johansen K. Time to rethink the timing of dialysis initiation. Arch Intern Med. 2011;171(5):382-83. Search in Google Scholar

52 Cooper B, Branley P, Bulfone L, Collins J, Craig J, Fraenkel M, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609-19. Search in Google Scholar

53 Ferguson T, Garg A, Sood M, Rigatto C, Chau C, Komenda P, et al. Association between the publication of the Initiating Dialysis Early and Late Trial and the timing of dialysis initiation in Canada. JAMA Intern Med. 2019;179(7):934-41. Search in Google Scholar

54 National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884-930. Search in Google Scholar

55 Dahlerus C, Quinn M, Messersmith E, Lachance L, Subramanian L, Perry E, et al. Patient perspectives on the choice of dialysis modality: results from the empowering patients on choices for renal replacement therapy (EPOCH-RRT) study. Am J Kidney Dis. 2016;68(6):901-10. Search in Google Scholar

56 Gallieni M, Hollenbeck M, Inston N, Mick Kumwenda, Powell S, Tordoir J, et al. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transplant. 2019;34(2):1-42. Search in Google Scholar

57 Niyyar V, Wasse H. Vessel mapping for dialysis access planning. Semin Dial. 2017;30(4):305-8. Search in Google Scholar

58 Borisov B, Iliev S. Superficialization of the outflow vein in case of a cubital fistula - always or sometimes? Pol Przegl Chir. 2019 Mar 28;91(3):6-9. Search in Google Scholar

59 Woodside K, Repeck K, Mukhopadhyay P, Schaubel D, Shahinian V, Saran R, et al. Arteriovenous vascular access-related procedural burden among incident hemodialysis patients in the United States. Am J Kidney Dis. 2021;78(3):369-79. Search in Google Scholar

60 Lyu B, Chan M, Yevzlin A, Astor B. Catheter Dependence After Arteriovenous Fistula or Graft Placement Among Elderly Patients on Hemodialysis. Am J Kidney Dis. 2021;78: 399–408. Search in Google Scholar

61 Borisov B, Iliev S. Supraclavicular Approach to the Subclavian Vein - One Well Forgotten Technique with Impressive Results. Pol Przegl Chir. 2019 Jun 6;91(4):19-23. Search in Google Scholar

62 Chinese Peritoneal Dialysis Expert Group. Guidelines for peritoneal dialysis in China. Chin J Nephrol. 2016;32:867-71. Search in Google Scholar

63 Yang X-H, Sun R-H, Zhao M-Y, Chen E-Z, Liu J, Wang H-L, et al. Expert recommendations on blood purification treatment protocol for patients with severe COVID-19. Chronic Dis Transl Med. 2020;6(2):106-14. Search in Google Scholar

64 Hallan S, Rifkin D, Potok O, Katz R, Langlo K, Bansal B, et al. Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate. Kidney Int. 2019;96(3):728-37. Search in Google Scholar

65 Obi Y, Streja E, Rhee C, Ravel V, Amin A, Cupisti A, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(2):256-65. Search in Google Scholar

66 Grooteman M, Nubé M. Reappraisal of hemodiafiltration for managing uremic complications. Clin J Am Soc Nephrol. 2021;16(9):1303-05. Search in Google Scholar

67 Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487-97. Search in Google Scholar

68 Imamovic G, Hrvacevic R, Kapun S, Marcelli D, Bayh I, Grassmann A, et al. Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis. Int Urol Nephrol. 2014;46(6):1191-200. Search in Google Scholar

69 O’Brien F, Fong K, Sirich T, Meyer T. More dialysis has not proven much better. Semin Dial. 2016;29(6):481-90. Search in Google Scholar

70 Jansz T, Noordzij M, Kramer A, Laruelle E, Couchoud C, Collart F, et al. Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry. Nephrol Dial Transplant. 2020;35(3):488-95. Search in Google Scholar

71 Kramer H, Yee J, Weiner D, Bansal V, Choi M, Brereton L, et al. Ultrafiltration rate thresholds in maintenance hemodialysis: an NKF-KDOQI controversies report. Am J Kidney Dis. 2016;68(4):522-32. Search in Google Scholar

72 Suranyi M, Chow J. Review: anticoagulation for haemodialysis. Nephrol (Carlton). 2010;15(4):386-92. Search in Google Scholar

73 Davies S. The elusive promise of bioimpedance in fluid management of patients undergoing dialysis. Clin J Am Soc Nephrol. 2020;15(5):597-99. Search in Google Scholar

74 Bioimpedance Devices for the Assessment of Body Fluid Volume for Patients Undergoing Dialysis: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines – An Update [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. 2015 [cited 2023 Apr 18];PMID: 26985542. Available from: https://www.ncbi.nlm.nih.gov/books/NBK349965/ Search in Google Scholar

75 Dasgupta I, Thomas G, Clarke J, Sitch A, Martin J, Bieber B, et al. Associations between hemodialysis facility practices to manage fluid volume and intradialytic hypotension and patient outcomes. Clin J Am Soc Nephrol. 2019;14(3):385-93. Search in Google Scholar

76 Cho Y, Bello A, Levin A, Lunney M, Osman M, Feng Y, et al. Peritoneal dialysis use and practice patterns: an international survey study. Am J Kidney Dis. 2021;77(3):315-25. Search in Google Scholar

77 Brown E, Blake P, Boudville N, Davies S, de Arteaga J, Dong J, et al. International Society for peritoneal dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020;40(3):244-53. Search in Google Scholar

78 Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, John Moran, Kopple JD, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011;58(3):418-28. Search in Google Scholar

79 Hao N, Cheng B, Yang H, Wu, Lei Y, Chao M, et al. Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study. BMC Nephrol. 2019;20(1):254. Search in Google Scholar